News-Yantai zhengfang pharmaceutical_Health Products

zhengfangyingxiao@qq.com

Scientific and technological innovation · People -oriented

NEWS

Is a modern pharmaceutical enterprises, mainly engaged in the treatment of diabetes, cardiovascular and cerebrovascular, liver disease, antiviral drugs and other research and development, production and sales.The company covers

Home page

Company News

Industry News

Li Keqiang calls for basic drug catalog adjustment to focus on cancer, pediatrics, chronic diseases and other diseases

Premier Li Keqiang presided over a State Council executive meeting on Aug. 30, which decided to transfer 187 Chinese and Western medicines with clear effectiveness and safety, and significant cost-benefit ratios, to the national essential drugs catalog.

03 Sep,2018

Director of the General Administration of Food and Drug Administration: GSP certification will be completely abolished

"GMP and GSP certifications will all be canceled." On September 24, at the 2017 China Pharmaceutical Entrepreneur Scientist Investor Conference held in Beijing, Ding Jianhua, director of the regulatory department of the General Administration of Food and Drug Administration, said.

27 Sep,2017

< 1 2 >